Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — New Federally Financed Research Finds Medical Marijuana Helpful in Combating Anxiety

A recent study partially funded by the National Institute on Drug Abuse (NIDA) has found that medical cannabis use is linked to noticeable improvements in anxiety and depression symptoms.

The research, published in the Journal of Affective Disorders, followed 33 adults from Maryland dealing with clinically diagnosed depression and/or anxiety. The study monitored their progress over six months, checking in at the start and again after one, three, and six months of using medical marijuana.

Results showed significant reductions in depression and anxiety, with many patients reporting improvements significant enough to drop below clinical thresholds within the first three months. Patients continued to report relief throughout the six-month period.

Most participants opted for marijuana products that were high in THC. While many experienced mental health benefits, they also reported feeling more intoxicated and less confident in their ability to drive safely. Researchers noted that the effects varied with the dose, and the most noticeable symptom relief came from using at least three puffs of vaporized marijuana or up to 15mg of oral THC.

Among those involved in the study, 75% had used cannabis at some point in the past, and around 37% had consumed it within the last year. Although medical cannabis was legal in Maryland during the study, recreational use was still against the law at that time.

The research team included experts from Johns Hopkins University’s School of Medicine, School of Public Health, and Cancer Center, along with collaborators from the Center for Alcohol Policy Research in Australia. Some of the researchers had ties to the cannabis industry, which was disclosed in the study’s conflict of interest section.

Despite the encouraging findings, the authors stressed the need for more rigorous clinical trials to better understand how safe and effective medical marijuana is for treating depression and anxiety.

There’s growing interest in the mental health effects of cannabis, especially as psychedelics and other alternatives gain traction. Past studies suggest that access to legal cannabis might reduce the need for prescription medications like antidepressants, antipsychotics, and anti-anxiety drugs. Other studies point to CBD as a potential treatment for depression and anxiety, with fewer side effects.

More broadly, people using medical marijuana for chronic pain have reported better sleep and improved mental health, adding to the growing evidence that cannabis could play a supportive role in treating emotional and psychological challenges.

These research findings support the medicinal use of marijuana products sold by numerous companies like TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) in outlets found in jurisdictions that have reformed their marijuana laws to permit medical and/or recreational cannabis sales.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — How Marijuana is Bringing Variety to Cuisine

Cannabis has come a long way from the days of basic pot brownies. With legalization spreading and chefs exploring new frontiers, marijuana is finding its place in modern kitchens as a versatile and flavorful ingredient. Rather than focusing just on the psychoactive effects, today’s cannabis cuisine emphasizes taste, aroma, and the unique characteristics of each compound.

Here are seven ways marijuana is changing the food world:

Infused Bases Like Tinctures, Oils, and Butters

Cannabis compounds such as CBD and THC can be infused into alcohol, oils, or butter, allowing for precise control over dosage and effects. The infused bases can then be used in a variety of recipes, from baked snacks to pasta sauces. The secret lies in activating the plant’s compounds through decarboxylation before adding them to recipes.

Flavor Pairing with Terpenes

Cannabis has natural scent compounds called terpenes, which are also found in fruits, herbs, and spices. These give each strain its distinct aroma and flavor, whether it’s citrusy, piney, earthy, or floral.

Chefs are learning how to match the terpene profile of a strain with specific ingredients in a dish. For example, a citrus-heavy strain might enhance a lemony chicken dish, while a strain with earthy tones could pair well with a mushroom risotto.

Savory Cannabis Recipes

Cannabis isn’t just for desserts anymore. Cooks are bringing it into main courses and sides. From salad dressings with cannabis-infused oils to roasted vegetables brushed with THC-rich butter or grilled meats marinated with cannabis blends. The plant’s herbal, sometimes peppery flavor can add subtle depth to savory foods.

Elevated Edibles and High-End Dining

Gone are the days of mystery brownies with unpredictable potency. Today’s cannabis edibles are crafted with care, focusing on taste, appearance, and consistent potency. Fine dining restaurants now serve multi-course meals infused with cannabis, where each plate is made to highlight the plant’s flavors and effects.

CBD-Infused Foods for Wellness

CBD, the non-intoxicating compound in cannabis, is gaining popularity in the health and food scenes. From CBD smoothies and teas to savory meals with a relaxing twist, the compound is being used to create dishes that offer calming benefits without the high.

Infused Drinks

Cannabis beverages are evolving beyond simple sodas. Bartenders and mixologists are crafting infused mocktails, cocktails, sparkling waters, and herbal teas. These drinks often kick in faster than edibles and offer a fun, social way to consume cannabis.

Cooking Classes and Cannabis Education

Interest in marijuana cooking is driving demand for professional training. Private instructors and culinary schools are offering courses that teach the science and art behind cannabis cuisine, covering safety, flavor pairing, dosage, and legal guidelines. This shift is helping legitimize marijuana in the kitchen and giving more people the skills to use it confidently.

The fusion of cannabis and cuisine is changing how people think about both. As knowledge spreads and public attitudes evolve, expect more inventive and flavorful cannabis dishes to take center stage in kitchens worldwide.

If you still thought consuming cannabis required you to walk into a retail outlet of a licensed company like SNDL Inc. (NASDAQ: SNDL) in order to pick up flower or prerolls, your options are increasing as the substance finds its way into cuisine in more innovative ways.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Anxiety Tops Qualifying Conditions in Pennsylvania’s Medical Marijuana Program

Pennsylvania’s move to allow medical cannabis for treating anxiety has significantly influenced how the state’s marijuana program functions, according to a recent University of Pittsburgh study.

Researchers found that anxiety is now the most frequently reported reason patients receive medical cannabis certifications, surpassing chronic pain. Pennsylvania became the third state to officially include anxiety as a valid condition for medical cannabis in 2019.

While more people are turning to cannabis to manage anxiety, the researchers warn that scientific support for its effectiveness in treating anxiety remains limited. Dr. Coleman Drake, a public health expert at Pitt, expressed concern that allowing anxiety as a qualifying condition may lead patients to believe that cannabis is a proven treatment for it, even though evidence is still lacking.

Drake pointed out that although marijuana might help certain individuals depending on their situations, the overall understanding of its medical benefits is still incomplete. He attributed this gap in knowledge to longstanding federal restrictions on cannabis research and limited access to detailed data from both medical and recreational marijuana programs.

The study’s authors reviewed data from the state’s Department of Health covering over 1.7 million certifications for medical marijuana issued between late 2017 and the end of 2023. To obtain these certifications, patients must receive a licensed physician’s recommendation and renew their approval each year.

Before anxiety was added as an approved condition, most patients were using the program for chronic pain (about 67%), followed by post-traumatic stress disorder (PTSD) at 16%. But after 2019, anxiety jumped ahead, becoming the most cited reason at 60%, while chronic pain dropped to 41% and PTSD to 11%. During this time, the number of certifications issued each month nearly tripled. Many of these certifications listed more than one qualifying condition.

The study, conducted in partnership with Johns Hopkins University and published in Annals of Internal Medicine, noted that it is unclear how many patients already using cannabis added anxiety to their diagnoses versus how many new patients joined the program specifically for anxiety treatment. Because of this, the exact impact of including anxiety on the overall size and growth of the program remains uncertain.

The researchers emphasized the need for more detailed research, especially as cannabis use continues to grow and regulations evolve. “There is an urgent need to better understand how cannabis is being used and what effects it is having,” Drake stated.

The broader marijuana industry, including firms like Green Thumb Industries Inc. (CNX: GTII) (OTCQX: GTBIF), hopes that federal restrictions impeding marijuana research are quickly reformed so that extensive studies can be conducted to document the exact effects that marijuana has on its medical users.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Adult-Use Marijuana Sales to Start in Delaware on August 1

Delaware’s recreational cannabis sales will officially start on August 1, according to an announcement by state officials. This marks the first confirmed date for the launch of the state’s legal marijuana industry.

On opening day, only existing medical cannabis dispensaries will be allowed to sell to recreational customers. Although licenses have been issued to new businesses focused solely on adult-use cannabis, they are not yet ready to open their doors.

The rollout plan has drawn criticism from both advocates and potential new business owners, who argue that giving current medical dispensaries a head start gives them an unfair advantage. Many of these dispensaries have long denied lobbying for early access, but critics say the outcome speaks for itself.

Delaware legalized recreational cannabis in 2023, setting up a system that permits 125 licenses covering growing, testing, manufacturing, and retail. More than 1,200 applicants joined a lottery last year in hopes of securing a license. Applicants had to pay submission fees, with most applications costing $5,000 and license activation fees running up to $10,000.

Medical cannabis operators transitioning to the recreational market had to pay even higher fees—$100,000 for manufacturing or retail licenses and $200,000 for growing rights. Revenue from these fees helped fund a $4 million program to support social equity applicants, particularly those affected by past cannabis-related arrests or enforcement policies.

Many businesses have been in limbo since March, waiting for state officials to clarify when legal sales could begin. The market was originally supposed to launch in April but was delayed after the state couldn’t get FBI approval in time to complete background checks. As of mid-June, 43 applicants have cleared those checks.

Even with the launch now scheduled, Delaware legislators are still adjusting the legal framework. Some towns and counties have used their authority to block cannabis businesses or impose strict location rules. A bill aimed at reducing these barriers has passed both chambers of the legislature and awaits the governor’s decision.

All seven of the state’s medical cannabis companies have made the transition to recreational sales and plan to operate at over ten locations in August. Meanwhile, other businesses face zoning issues, delayed funding, and incomplete approvals, putting them at a disadvantage.

Despite the rocky rollout, Delaware’s cannabis commissioner, Joshua Sanderlin, says the focus remains on building a safe and fair market. He confirmed that the state will continue issuing conditional licenses to help new operators open their doors as soon as possible.

Given all the delays and hiccups that have plagued the planned rollout of recreational sales in Delaware, other industry actors like Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) in other markets hope that this time round, sales are launched and any pending issues are resolved in due course.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — New Study Shows Cannabis Use is Linked to Higher Arousal, Sexual Desire

A new study suggests that cannabis use may be linked to higher levels of sexual interest, increased arousal, and reduced anxiety related to sex. The research, part of a doctoral dissertation from Queen’s University in Canada, is based on two separate studies.

One included an online questionnaire completed by 1,547 marijuana users. The other was a month-long diary study involving 115 participants—87 regular users and 28 who either used it rarely or not at all.

According to researcher Kayla M. Mooney, those who used cannabis more frequently tended to report stronger sexual desire. On days when they engaged in sexual activity, their arousal and desire were significantly higher if they had used marijuana that day. The study also revealed that even on days without sexual activity, cannabis users still noted a higher level of desire and felt less sexual distress compared to days when they didn’t consume marijuana.

Around half of the survey respondents said they used cannabis with sex in mind, often to improve aspects of the experience, such as sensation or connection. The study acknowledges that the link between marijuana and sex is complex, yet it contributes valuable insights to a growing body of work exploring how cannabis affects intimacy and sexual health.

Previous research supports some of these findings. For instance, a study published last year found that marijuana-based vaginal suppositories helped reduce pain during sex for women recovering from gynecological cancers. When combined with mindfulness-based compassion exercises, the results were even more positive.

Another study showed that CBD-rich vaginal suppositories may help ease menstrual symptoms and lessen their disruption to daily life.

In terms of sexual satisfaction, some evidence points to marijuana being more effective than alcohol. While alcohol might make someone feel more outgoing or attractive, cannabis appears to heighten physical sensations and overall enjoyment during sex.

A comprehensive review published in the Psychopharmacology Journal found that marijuana use is generally linked to more frequent sex and higher levels of pleasure. However, the review cautioned that smaller amounts may be more beneficial, as higher doses might reduce desire or impair performance. The review also noted that the effects can differ between women and men.

For women in particular, advocates have suggested that marijuana could potentially be used to treat sexual dysfunctions, such as female orgasmic disorder. In men, the data is less clear—some studies suggest marijuana may hinder performance, while others report improved outcomes.

These studies further cement the beneficial effects of using marijuana products from a variety of sources like Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) and make a case for jurisdictions having restrictions to ease them so that people who could benefit from these products can access them legally.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Nebraska Commission Finalizes Emergency Medical Marijuana Regulations

The Nebraska Medical Cannabis Commission recently signed off on emergency rules that would let the state begin accepting applications for medical marijuana licenses once Governor Jim Pillen gives the official go-ahead. State law requires the governor to act by July 1.

The emergency guidelines were revealed just minutes before the commission’s 10 a.m. meeting. The temporary rules, which closely resemble a bill that stalled in the Legislature last month, could be in effect for up to 90 days, depending on Pillen’s approval. The voter-approved measures legalizing medical marijuana require that applications start being accepted by July 1.

Commissioner Lorelle Mueting said the commission is open to public input on the regulations until July 15. Anyone wishing to comment can email the Nebraska Liquor Control Commission, which will forward the messages to the medical marijuana commission.

Commission chair Dr. Monica Oldenburg plans to send a letter to Governor Pillen outlining the urgency of adopting the emergency rules. She warned that without them, residents might turn to unregulated and potentially unsafe alternatives.

A spokesperson for the governor confirmed that Pillen is currently reviewing the regulations and expects to make a decision by the July 1 deadline.

State law requires the licensing process for cannabis businesses to begin by October 1. Under the emergency framework, licenses could be issued for growers, processors, retailers, and delivery services, but each applicant can only apply for one type of license.

Emergency rules can be justified under state law if there’s an immediate threat to public safety or welfare. Meanwhile, Oldenburg and Mueting will lead a subgroup to continue refining the rules.

The commission also voted to collaborate with the Department of Health and Human Services and the governor’s policy office to get legal support through DHHS.

A recent bill (LB 677) that would have added tighter regulations narrowly failed in the legislature. It would have permitted up to 30 dispensaries statewide. The emergency rules instead allow only one dispensary per judicial district—totaling 12—which has raised concerns from some marijuana advocates.

Additional restrictions include a ban on dispensaries near schools, churches, hospitals, or daycares. Applicants must have had majority ownership based in Nebraska for at least four years and be U.S. citizens. Background checks, including fingerprinting, are also required.

The rules don’t list qualifying health conditions, unlike LB 677, which named 15. Instead, patients must get a detailed recommendation from a licensed provider. Approved products include tablets, tinctures, lozenges, gels, creams, suppositories, patches, and oils for nebulizers or inhalers. Raw flower, edibles, flavored items, and anything designed for smoking or vaping are not allowed.

While LB 677 would have required strict testing before products reached patients, the emergency rules only suggest that products may be tested. The commission currently doesn’t have the authority to mandate testing without legislative changes.

Packaging must be tamper-proof, child-safe, and free from images or branding that could appeal to minors, including cartoon characters or celebrity likenesses.

Senator Ben Hansen, who introduced LB 677, said many elements of the emergency regulations appear to have been lifted from his bill. He noted the real test would come with the final version of the rules. He also raised concerns about potential lawsuits from the state Attorney General, which could challenge the commission’s authority and burden taxpayers.

Senator John Cavanaugh, co-sponsor of LB 677, noted that the commission lacks the power to limit marijuana product forms. Crista Eggers, who leads the group behind the ballot initiative, agreed, stating the law legalized all forms, including flower. She also noted it’s still unclear where applicants should send their completed paperwork.

After the meeting, Eggers said she sees positive steps being made, especially the commission’s openness to public feedback. Final regulations will be subject to a public hearing with at least 30 days’ notice. The next commission meeting is set for August 4, with a possible hearing on permanent rules to follow in September.

The broader marijuana industry, including leading firms like Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED), will be following how the legalization process plays out in Nebraska to enable qualifying patients to access licensed cannabis-based products to help them to address their symptoms.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Poll Finds Most Texas Voters Oppose Banning Hemp Products

A new poll shows that most Texas voters are not in favor of a full ban on hemp-based THC products. The survey revealed that 53% of voters were against the ban that state lawmakers had passed under SB 3. In contrast, just 31% said they were in favor of it.

The Republican base appeared split on the issue, with 46% in favor of banning the products, while 39% were against it. These opinions were collected in early June, shortly after the legislative session wrapped up but before Governor Greg Abbott vetoed the bill.

The veto immediately sparked backlash from Lieutenant Governor Dan Patrick, who had strongly pushed for the ban throughout the legislative process. Patrick, who leads the Texas Senate, also rejected Abbott’s idea to regulate THC products more strictly instead of banning them outright.

With lawmakers now gearing up for what may be a tense extra session, the poll highlighted how divided the public remains on this topic.

Senate Bill 3 aimed to outlaw consumable hemp products containing THC. Since hemp sales were legalized in Texas back in 2019, THC-infused products have become widely available in smoke shops and convenience stores.

After the veto, Patrick expressed strong frustration with Abbott, marking a rare public disagreement between two of the state’s highest-ranking leaders who typically see eye to eye. “This conflict was avoidable,” Patrick said. “Where has he been all this time? He shows up after midnight with reasons we just don’t agree with.”

Patrick warned that a recent court ruling in Arkansas could lead to consequences in Texas. He claimed that as many as 8,000 vape and smoke shops might be forced to close if similar legal decisions are made in the state.

Abbott referenced the Arkansas lawsuit in his veto announcement, saying the Texas bill likely wouldn’t hold up in court and would cause years of legal delays. He wrote on social media that, unlike Arkansas’s version, Texas’s proposal had legal flaws.

“Even with a stronger law in Arkansas, it sat unenforced for two years and is still being fought in court,” Abbott said. “We need action now to protect our children. That effort starts next month.” While Abbott has defended his decision online, he has not directly responded to Patrick’s public criticisms.

The recent poll also showed a shift in how Republican voters feel about cannabis laws. Ten years ago, 31% of GOP voters in Texas said cannabis should stay illegal. That number is now at 21%. At the same time, support among Republicans for legalizing small amounts of cannabis rose from 23% in 2015 to 31% as of April.

As public attitudes shift in Texas and other holdout states still having prohibitionist marijuana policies, the industry and leading firms like Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) will be watching and hoping that a time will come when adults in those jurisdictions who wish to consume marijuana will have legal sources for the substance.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Congress Promises to Consider Marijuana Banking Reform Once the Budget is Passed

Congress is expected to revisit cannabis-related issues this fall, including banking access for marijuana businesses, according to political experts in Washington.

David Culver, a top executive at the U.S. Cannabis Roundtable, a leading advocacy group, said he believes there’s a strong chance that Congress will approve the SAFE Banking measure before the current session ends. “This is the most promising window we’ve had so far,” Culver said in an interview.

However, the bill’s progress is on hold until Congress handles a top priority: President Trump’s One Big Beautiful Bill Act. Lawmakers from both parties agree that this bill takes precedence.

Senator Bernie Moreno, who is leading GOP support for the Senate version of the cannabis banking bill, said the Senate will likely turn its attention back to SAFER Banking sometime in the fall.

Currently, most congressional action is stalled as Republican legislators remain divided over Trump’s broad immigration and tax bill. GOP leaders in the Senate have said they aim to send the finalized bill to Trump by Independence Day. But complications arose when House Republicans pushed back on changes introduced in the Senate.

Representative Andy Harris, who heads the conservative House Freedom Caucus, stated that the House version must be the final framework. “Our red line is clear,” he told the Washington Post. “It needs to match what we passed in the House.”

Delays in reaching an agreement on Trump’s bill could stall other bills, including cannabis-related legislation.

Meanwhile, Harris is also backing a separate proposal that would change the legal definition of hemp at the federal level to ban products containing hemp-derived THC and THCA flower. However, the odds of that measure passing are low, especially since several GOP lawmakers represent states with booming hemp markets.

Cannabis banking had been at the top of the legislative agenda until the Biden administration moved to reclassify cannabis from Schedule I to III under the CSA in 2022. That change would offer immediate tax benefits to cannabis companies—something that banking reform alone wouldn’t provide.

But with rescheduling efforts currently stalled, attention is once again turning to the need for financial access. While the House has passed banking reforms several times under Democratic control, the Senate has yet to follow through.

Advocates say passing SAFER Banking could pave the way for more reforms, including standardized THC regulation and nationwide cannabis commerce.

Major marijuana industry players like Trulieve Cannabis Corp. (CNX: TRUL) (OTCQX: TCNNF) will be hoping that some regulatory reforms are enacted sooner rather than later given the numerous headwinds that the industry is currently facing.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Golden Triangle Ventures Inc. (OTC: GTVH) Restructures $7 Million in Legacy Debt, Secures Repurchase Option

Golden Triangle Ventures (OTC: GTVH) (“GTV”) has completed a major restructuring of its capital structure and legacy debt obligations through an agreement with a new third-party investor, who acquired all outstanding notes previously held by the Company’s largest creditor, T&K Zarro, LLC. The transaction consolidates five debt instruments totaling over $7 million and grants GTVH the exclusive right to repurchase the full balance for $4 million, offering a significant discount. The move simplifies GTVH’s balance sheet, supports disciplined growth and strengthens financial positioning.

To view the full press release, visit https://cnw.fm/t9t2O

About Golden Triangle Ventures Inc.

Golden Triangle Ventures is a multifaceted consulting company, which operates as the parent business pursuing ventures in the health, entertainment and technology sectors, along with others that provide synergistic value to these three core divisions. The company aims to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent the three sectors in which this company aims to do business. Golden Triangle Ventures is highly focused on acquiring a well-diversified portfolio of companies under one umbrella, which are all managed and owned by the company. An amazing team of professionals supports each division and continues to help the company grow daily. Being a publicly traded company gives the ability to provide the support needed to help each subsidiary grow into the business that management believes it can and will become. For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Austin, Texas
www.CannabisNewsWire.com
512.354.7000 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Ohio GOP Lawmaker Suggests Efforts to Legalize Cannabis Could Be Paused

State lawmakers in Ohio are likely to head into their summer recess without passing any revisions to the current cannabis regulations.

Senate Bill 56 (SB 56), which proposes revisions to Ohio’s recreational cannabis laws, has been stalled in the House Judiciary Committee for two consecutive weeks. The committee canceled a scheduled meeting this week, which only listed SB 56 on its agenda, and previously removed the bill from the agenda altogether.

“We’re hitting pause for the summer,” Representative Brian Stewart said. “We might come back to it later and try again.”

The Senate approved the bill in February, but it needs approval from the House before it can become law. House Speaker Matt Huffman explained that while the Senate is eager to move forward, the House doesn’t want to compromise its legislative goals just to pass the legislation quickly.

Currently, legislators are finalizing the state’s two-year budget, which must be finalized by July 1. Once that’s done, the legislature will begin its summer recess.

SB 56 proposes lowering the THC cap in recreational cannabis extracts from 90% to 70%, capping dispensaries at 400 locations, and restricting smoking in most public areas. It keeps the existing home-grow rules at six plants per adult and 12 per household. The bill, introduced in January by Senator Steve Huffman, originally aimed to cut the home-grow limit in half.

Voters approved recreational cannabis in 2023 through a citizen-led initiative, which passed with 57% support. Retail sales began in August 2024. Since the law originated from a citizen petition and not an amendment, lawmakers have the authority to amend it.

House Democrats argue that the bill undermines the will of the voters. Representative Dani Isaacsohn said, “Ohioans chose to legalize recreational cannabis. They understood the measure and supported it.”

Among the most debated provisions are new restrictions on hemp products. Currently, the bill states that only licensed dispensaries can sell the products, which would need to meet strict advertising, packaging, and labeling rules. However, stores like groceries, restaurants, and convenience shops can still sell hemp-infused beverages. Oversight would fall to the state’s Commerce Department.

Isaacsohn agrees that hemp rules are necessary but wants them handled separately. Meanwhile, Representative D.J. Swearingen, who had planned to present changes to the hemp portion of the bill, was unable to do so due to the canceled committee meeting.

He worked with the American Republic Policy on proposals that would let existing hemp businesses keep their doors open. Dakota Sawyer from the group said the goal was to prevent monopolies and allow small businesses to continue operating outside the dispensary model.

Governor DeWine and some lawmakers have voiced concerns about minors accessing hemp products. But Sawyer pointed out that the average Ohio hemp consumer is about 40 years old. He accused some legislators of exaggerating risks to justify restrictions.

Sawyer suggested splitting marijuana and hemp legislation into two separate bills, arguing that combining them only complicates progress.

The discussions in Ohio are likely to attract interest from far and wide, including from firms like Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY), given how high the stakes are, including the regulation of hemp products within state borders.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com